Trial site
The 2nd Affiliated Hospital of Harbin Medical University
- 11running trials
- 7closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Stroke7 trials
- Coronary artery disease2 trials
- Atrial fibrillation1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- Hydrocephalus1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Macular degeneration1 trial
- Prostate cancer1 trial
- Psoriasis1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed6 trials
- Not yet recruiting5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Beijing Tiantan Hospital5 trials
- Bayer1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Beijing Sungen Biomedical Technology Co., Ltd1 trial
- Biotronik SE & Co. KG1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Coronary artery disease1 recruiting
- Hydrocephalus1 recruiting
- Lupus (SLE)1 recruiting
- Macular degeneration1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Completed
Completed
Completed
Completed
Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Completed
Terminated
Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease
Site data: ClinicalTrials.govUpdated 19 Nov 2026